Patrizia Scaini

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Journal: Clinical rheumatology

Published: October 20, 2022

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

Journal: Clinical rheumatology

Published: July 06, 2022

Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach.

Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach.

Journal: Clinical and experimental rheumatology

Published: March 23, 2020

Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome.

Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome.

Journal: Autoimmunity reviews

Published: February 14, 2019

HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC).

HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC).

Journal: Clinical and experimental rheumatology

Published: January 19, 2017

Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Journal: Journal of autoimmunity

Published: June 21, 2015

Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.

Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: February 27, 2015

Validation of the classification criteria for cryoglobulinaemic vasculitis.

Validation of the classification criteria for cryoglobulinaemic vasculitis.

Journal: Rheumatology (Oxford, England)

Published: July 05, 2014

Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.

Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.

Journal: Clinical and experimental rheumatology

Published: June 10, 2012

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.

Journal: Journal of nephrology

Published: January 02, 2012

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

Journal: Arthritis and rheumatism

Published: December 08, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026